Open AccessComparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis
Author(s) -
Huajiang Shen,
Feng Ding,
Zhiwei Wang,
Fang Sun,
Yafeng Yu,
Jiankang Zhou,
Wenfang Xu,
Jianchao Ni,
Jiangang Wang,
Yida Yang
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000452552
Subject(s) - entecavir , medicine , telbivudine , renal function , cirrhosis , creatinine , gastroenterology , hepatitis b , drug resistance , urology , hepatitis b virus , lamivudine , immunology , virus , microbiology and biotechnology , biology
To compare the impact of telbivudine (LDT) and entecavir (ETV) administration on nephritic function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom